Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 09:34pm US/Eastern

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664

© Business Wire 2013
React to this article
Latest news
Date Title
04:33a DIOS FASTIGHETER : Diös Fastigheter double its property portfolio in Skellefteå
04:33a CHINA ENVIRONMENTAL TECHNOLOGY : Monthly Return of Equity Issuer on Movements in Securities for the Month Ended September 30, 2015
04:33a ADVANCED SEMICONDUCTOR ENGINEERING : An Open Letter to SPIL Shareholders from ASE (I)
04:33a CBRAIN A/S : You don't have to be Danish to get great IT
04:33a ERICSSON : Device Connection Platform chosen by Brighter for m-health delivery
04:33a NEOPOST : Number of shares and voting rights - August 2015
04:33a HRVATSKI TELEKOM DD : Notification of transactions of directors/persons discharging managerial responsibilities and connected persons
04:31aDJRussia Services Sector Expands, Confidence Improves--PMI Survey
04:30a GLENCORE : shares jump amid reports firm is open to offers
04:29a Oil up as Russia mulls OPEC talks, rig count drops
Latest news
Hot News 
CLOUDBUY : Appointment of NOMAD and Broker and Restoration to Trading on AIM
UBS : Start of renovation of UBS's head office and opening of a new, temporary branch
PRESS : Capita And Apollo Competing To Buy Xchanging - FT
NASSTAR : Acquires VESK Group For GBP7.8 Million In Cash And Shares (ALLISS)
EDGE THERAPEUTICS : Announces Pricing of Its Initial Public Offering
Most Read News
10/04DJTrans-Pacific Partnership Trade Deal Within Reach
01:05a After Mandatory Tender Offer Renova will own 62,86% of Sulzer AG
10/04 BIO Statement on Data Exclusivity Provisions Within the Trans-Pacific Partnership
10/04 How to address fears surrounding economic corridor
10/04 An Open Letter to SPIL Shareholders
Most recommended articles
04:31aDJRussia Services Sector Expands, Confidence Improves--PMI Survey
04:29a Oil up as Russia mulls OPEC talks, rig count drops
04:19a Welsh stem cell firm wins fast-track filing path in Europe
04:13aDJGlencore Shares Jump
04:09aDJLONDON MARKETS : FTSE 100 Gains For Fourth Day As Miners Rise